You are here

Aptalis

Pharma's top 10 M&A deals of 2014's first half

Fierce Pharma

Mon, 11/3/14 - 08:57 am

Questcor Pharmaceuticals

Health-Care Deals Make Explosive Start to 2014

Motley Fool

Mon, 03/3/14 - 09:13 pm

Bristol-Myers Squibb

3 Major Health-Care Deals You Need to Know About

Motley Fool

Tue, 02/11/14 - 04:48 pm

Bristol-Myers Squibb

Forest Labs completes $2.9B acquisition of Aptalis

Yahoo/Fly on the Wall

Mon, 02/3/14 - 08:54 am

Forest Raises $1.8 Billion in Bond Sale to Fund Aptalis Takeover

Bloomberg/Businessweek

Tue, 01/28/14 - 12:18 pm

Forest Labs to buy private peer Aptalis for $2.9 bln

Yahoo/Reuters

Wed, 01/8/14 - 08:03 am

TPG-backed drugmaker Aptalis files for IPO of up to $500 mln

Reuters

Thu, 12/26/13 - 09:45 am

Aptalis Pharma Begins Promotion of RECTIV(TM) to Physicians in the U.S.

Health Care Global

Sat, 03/17/12 - 12:38 pm

Aptalis Pharma Announces FDA Approval of 25,000 Lipase-Unit Strength of ZENPEP(R)

Pipeline Review

Sat, 07/16/11 - 12:07 pm

exocrine pancreatic insufficiency

cystic fibrosis

Axcan completes buyout of Eurand

Yahoo/AP

Sat, 02/12/11 - 12:52 pm

Axcan buying Eurand for $583 million

Yahoo/AP

Wed, 12/1/10 - 11:35 am

Cephalon settles patent dispute over muscle relaxer

Yahoo/AP

Wed, 10/13/10 - 11:57 am

muscle relaxants

Eurand Announces Data on Switching Cystic Fibrosis Patients With Exocrine Pancreatic Insufficiency From Unapproved PEPs to FDA-Approved ZENPEP(R)

Yahoo/MarketWire

Thu, 06/17/10 - 08:46 am

exocrine pancreatic insufficiency

Eurand N.V. Q1 2010 Earnings Call Transcript

Seeking Alpha

Sat, 05/15/10 - 11:59 am

Eurand says FDA approved pancreatic enzyme Zenpep

Yahoo/AP

Fri, 08/28/09 - 12:00 pm

Eurand's ulcerative colitis drug candidate for children gets FDA orphan drug status

Yahoo/AP

Tue, 03/10/09 - 10:30 am

ulcerative colitis

FDA Issues Complete Response Letter to GlaxoSmithKline for Eurand's EUR-1048

GlobeNewsWire

Sat, 12/27/08 - 11:22 am